Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Protective action of NDP-MSH in experimental subarachnoid hemorrhage.
Gatti S, Lonati C, Acerbi F, Sordi A, Leonardi P, Carlin A, Gaini SM, Catania A.
Exp Neurol. 2012 Mar;234(1):230-8. Epub 2012 Jan 2.
Related citations
Phrenic motoneuron expression of serotonergic and glutamatergic receptors following upper cervical spinal cord injury.
Mantilla CB, Bailey JP, Zhan WZ, Sieck GC.
Exp Neurol. 2012 Mar;234(1):191-9. Epub 2011 Dec 29.
Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects.
Blesch A, Lu P, Tsukada S, Alto LT, Roet K, Coppola G, Geschwind D, Tuszynski MH.
Exp Neurol. 2012 May;235(1):162-73. Epub 2011 Dec 29.
Treatments to restore respiratory function after spinal cord injury and their implications for regeneration, plasticity and adaptation.
Sharma H, Alilain WJ, Sadhu A, Silver J.
Exp Neurol. 2012 May;235(1):18-25. Epub 2011 Dec 19.
Controlled cortical impact injury and craniotomy result in divergent alterations of pyruvate metabolizing enzymes in rat brain.
Xing G, Ren M, O'Neill JT, Verma A, Watson WD.
Exp Neurol. 2012 Mar;234(1):31-8. Epub 2011 Dec 14.
Spinal cord injury with unilateral versus bilateral primary hemorrhage--effects of glibenclamide.
Simard JM, Popovich PG, Tsymbalyuk O, Gerzanich V.
Exp Neurol. 2012 Feb;233(2):829-35. Epub 2011 Dec 14.
Mammalian target of rapamycin (mTOR) inhibition reduces cerebral vasospasm following a subarachnoid hemorrhage injury in canines.
Zhang W, Khatibi NH, Yamaguchi-Okada M, Yan J, Chen C, Hu Q, Meng H, Han H, Liu S, Zhou C.
Exp Neurol. 2012 Feb;233(2):799-806. Epub 2011 Dec 8.
Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.
Simard JM, Tsymbalyuk O, Keledjian K, Ivanov A, Ivanova S, Gerzanich V.
Exp Neurol. 2012 Jan;233(1):566-74. Epub 2011 Dec 8.
A reassessment of a classic neuroprotective combination therapy for spinal cord injured rats: LPS/pregnenolone/indomethacin.
Popovich PG, Tovar CA, Wei P, Fisher L, Jakeman LB, Basso DM.
Exp Neurol. 2012 Feb;233(2):677-85. Epub 2011 Dec 8.
A reassessment of LPS/indomethacin/pregnenolone combination therapy after spinal cord injury in rats.
Guth L.
Exp Neurol. 2012 Feb;233(2):686. Epub 2011 Nov 23. No abstract available.
Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injury.
Liu G, Detloff MR, Miller KN, Santi L, Houlé JD.
Exp Neurol. 2012 Jan;233(1):447-56. Epub 2011 Nov 19.
Comprehensive locomotor outcomes correlate to hyperacute diffusion tensor measures after spinal cord injury in the adult rat.
Kim JH, Song SK, Burke DA, Magnuson DS.
Exp Neurol. 2012 May;235(1):188-96. Epub 2011 Nov 19.
A re-assessment of the effects of treatment with an epidermal growth factor receptor (EGFR) inhibitor on recovery of bladder and locomotor function following thoracic spinal cord injury in rats.
Sharp K, Yee KM, Steward O.
Exp Neurol. 2012 Feb;233(2):649-59. Epub 2011 Nov 10.
Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury.
Weaver LC, Dekaban GA, Brown A.
Exp Neurol. 2012 Feb;233(2):612-4. Epub 2011 Nov 10.
Replication and reproducibility in spinal cord injury research.
Steward O, Popovich PG, Dietrich WD, Kleitman N.
Exp Neurol. 2012 Feb;233(2):597-605. Epub 2011 Nov 10.
Response to the report, "A re-assessment of a combinatorial treatment involving Schwann cell transplants and elevation of cyclic AMP on recovery of motor function following thoracic spinal cord injury in rats" by Sharp et al. (this volume).
Bunge MB, Pearse DD.
Exp Neurol. 2012 Feb;233(2):645-8. Epub 2011 Nov 10. No abstract available.
One day of motor training with amphetamine impairs motor recovery following spinal cord injury.
Wong JK, Steward O.
Exp Neurol. 2012 Feb;233(2):693-707. Epub 2011 Nov 10.
Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.
Pisapia JM, Xu X, Kelly J, Yeung J, Carrion G, Tong H, Meghan S, El-Falaky OM, Grady MS, Smith DH, Zaitsev S, Muzykantov VR, Stiefel MF, Stein SC.
Exp Neurol. 2012 Jan;233(1):357-63. Epub 2011 Nov 4.
Evaluation of peripheral nerve regeneration via in vivo serial transcutaneous imaging using transgenic Thy1-YFP mice.
Yan Y, Sun HH, Mackinnon SE, Johnson PJ.
Exp Neurol. 2011 Nov;232(1):7-14. Epub 2011 Jul 1.
Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury.
Jeong SR, Kwon MJ, Lee HG, Joe EH, Lee JH, Kim SS, Suh-Kim H, Kim BG.
Exp Neurol. 2012 Jan;233(1):312-22. Epub 2011 Oct 31.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on